Biotechnological Certest updates its brand claim
The Spanish company has decided to renew its value proposition by focusing on a rigorous biotechnology with a guarantee of trust.
Many things have changed over the nearly 25 years in which Certest has been developing, manufacturing, and commercializing in vitro diagnostic devices. These changes have led the company to become the global organization it is today, with more than 300 employees working in facilities spanning over 35,000 square meters, structured around four business areas: Raw Materials under the Alaset brand; Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA); Molecular Biology (PCR and NGS) under the VIASURE brand; and Pharma, specialized in the development of advanced lipid nanoparticles for the creation of next-generation medicines.
And since growth also means evolution, the brand claim used until now — “More than diagnostics” — is no longer sufficient to explain the essence of Certest. The reality is that today it is much more than diagnostics.
For this reason, the company has decided to renew itself by focusing on comprehensive biotechnology with a guarantee of trust, developed ad hoc for its clients from the initial idea to its real-world application, fully adapting to each client’s needs. This service has recently begun to be marketed through its service platform, Certekia.
In this way, Certest embarks on a new stage in its journey with its new claim: “From Discovery to Delivery, Biotech You Can Trust”.